Optimization of cells for endogenous gene activation
First Claim
1. A process for changing the expression of a nucleic acid sequence which is present endogenously in a eukaryotic cell, the method comprising(a) transfecting the cell with a vector comprising the following sequences (i) at least one sequence, which upon expression is capable of changing the expression of the nucleic acid sequence which is present endogenously in the cell, and selected from the group consisting of a heterologous expression control sequence and an amplification gene, (ii) a sequence encoding a positive selection marker, (iii) at least two target sequences for a site-specific recombinase flanking the sequences of (i) and (ii), and (iv) DNA sequences which flank the sequences of (i), (ii) and (iii) and are homologous to a nucleic acid section in the genome of the cell in order to allow a homologous recombination, (b) culturing the transfected cell under conditions under which a homologous recombination of the vector takes place, (c) isolating the cell obtained according to step (b), and (d) expressing the at least one sequence of (i) to thereby change the expression of the nucleic acid sequence which is present endogenously in the cell.
2 Assignments
0 Petitions
Accused Products
Abstract
The invention concerns a process for optimizing the gene expression in cells. A first aspect concerns a process for changing the expression of a nucleic acid sequence which is present endogenously in a eukaryotic cell by introduction of a heterologous expression control sequence into the genome of the cell by means of homologous recombination as well as site-specific recombinase-mediated excision of inserted foreign DNA and its replacement by further heterologous expression control sequences or/and amplification genes. In addition the invention concerns the introduction of one or several nucleic acid sequences to which an activator protein or an activator protein complex binds e.g. a hypoxia-inducible factor (HIF), into the genome of a eukaryotic cell by homologous recombination in order to change the expression of a target gene. Furthermore the invention concerns a process for testing the influence of 5′ or 3′ non-coding nucleic acid fragments on the expression of a target gene by determining the expression of a reporter gene. In addition the invention concerns a process for providing a DHFR-negative eukaryotic cell containing a recombinase target sequence as well as the expression of a nucleic acid sequence inserted into the recombinase target sequence.
-
Citations
24 Claims
-
1. A process for changing the expression of a nucleic acid sequence which is present endogenously in a eukaryotic cell, the method comprising
(a) transfecting the cell with a vector comprising the following sequences (i) at least one sequence, which upon expression is capable of changing the expression of the nucleic acid sequence which is present endogenously in the cell, and selected from the group consisting of a heterologous expression control sequence and an amplification gene, (ii) a sequence encoding a positive selection marker, (iii) at least two target sequences for a site-specific recombinase flanking the sequences of (i) and (ii), and (iv) DNA sequences which flank the sequences of (i), (ii) and (iii) and are homologous to a nucleic acid section in the genome of the cell in order to allow a homologous recombination, (b) culturing the transfected cell under conditions under which a homologous recombination of the vector takes place, (c) isolating the cell obtained according to step (b), and (d) expressing the at least one sequence of (i) to thereby change the expression of the nucleic acid sequence which is present endogenously in the cell.
-
5. A vector suitable for homologous recombination, comprising the following sequences
(i) at least one sequence selected from the group consisting of an expression control sequence and an amplification gene each of which upon expression is capable of changing the expression of the nucleic acid sequence which is present endogenously in the cell, (ii) a sequence encoding a positive selection marker, (iii) at least two target sequences for a site-specific recombinase flanking the sequences of (i) and (ii), and (iv) DNA sequences which flank the sequences of (i), (ii) and (iii) and are homologous to a nucleic acid section in the genome of a cell in order to allow a homologous recombination, and (v) optionally a sequence encoding a negative selection marker.
-
6. A vector, comprising
(i) at least one sequence selected from the group consisting of a heterologous expression control sequence and an amplification gene each of which upon expression is capable of changing the expression of the nucleic acid sequence which is present endogenously in the cell, (ii) a sequence encoding a positive selection marker, (iii) at least two recombinase target sequences flanking the sequences of (i) and (ii), and (iv) optionally a sequence encoding a negative selection marker.
-
7. A eukaryotic cell, comprising
(a) at least one chromosomally-located sequence selected from the group consisting of a heterologous expression control sequence and an exogenous amplification gene in operative linkage with a nucleic acid sequence which is present endogenously in the cell, and (b) recombinase target sequences flanking the sequence (a).
-
9. A process for changing the expression of a nucleic acid sequence which is present endogenously in a eukaryotic cell, the method comprising
(a) transfecting the cell with a vector comprising (i) at least one nucleic acid sequence which binds an activator protein, (ii) a sequence encoding a positive selection marker, and (iii) DNA sequences which flank the sequences of (i) and (ii) and are homologous to a nucleic acid section in the genome of the cell in order to allow a homologous recombination, (b) culturing the transfected cell under conditions under which a homologous recombination of the vector takes place, (c) isolating the cell obtained according to step (b), and (d) expressing the sequence of (i) under conditions under which the activator protein is bound thereby changing the expression of the nucleic acid sequence which is present endogenously in the cell.
-
13. A vector suitable for homologous recombination, comprising
(i) at least one nucleic acid sequence which binds an activator protein, (ii) a positive selection marker gene, and (iii) DNA sequences which flank the sequences (i) and (ii) and are homologous to a nucleic acid section in the genome of a cell in order to allow a homologous recombination.
- 14. A eukaryotic cell, comprising at least one chromosomally-located exogenous nucleic acid sequence which binds an activator protein/activator protein complex which is operatively linked with a gene which is present endogenously in the cell.
-
16. A process for testing the influence of non-coding nucleic acid sequences from the region of a target gene present endogenously in a eukaryotic cell on its expression, the process comprising
(a) transfecting the cell with a vector comprising (i) a heterologous expression control sequence which is active or can be activated in the cell and is operatively linked with a reporter gene, and (ii) non-coding nucleic acid sequences on the 5′ - -side and/or the 3′
-side from the region of the target gene,(b) culturing the cell under conditions under which the expression control sequence is active, and (c) measuring the expression of the reporter gene to determine the influence of the non-coding nucleic acid sequences on the expression of the target gene.
- -side and/or the 3′
-
17. A process for obtaining a DHFR-negative eukaryotic cell, the process comprising
(a) transfecting a DHFR-positive cell with a first vector comprising (i) at least one DHFR-negative target sequence for a site-specific recombinase; -
(ii) DNA sequences which flank sequence (i) and are homologous to a DHFR nucleic acid sequence which is present endogenously in the cell in order to allow a homologous recombination, (iii) optionally a sequence encoding a first positive selection marker, and (iv) optionally a sequence encoding a negative selection marker, (b) culturing the transfected cell under conditions under which a homologous recombination of the vector takes place thereby incorporating the DHFR-negative target sequence into the DHFR-positive cell to create a DHFR-negative cell, and (c) isolating the cells obtained according to step (b) to obtain a DHFR-negative eukaryotic cell. - View Dependent Claims (18, 19)
-
-
20. A vector, comprising
(i) a nucleic acid sequence coding for a DHFR, (ii) a nucleic acid sequence to be amplified which codes for a protein in an expressible form, (iii) optionally a sequence encoding a positive selection marker, and (iv) at least two recombinase target sequences flanking the sequences of (i), (ii) and (iii), if present.
-
21. A vector suitable for homologous recombination, comprising
(i) optionally a sequence encoding a positive selection marker, (ii) at least one recombinase target sequence which flanks the sequence of (i), if present, (iii) DNA sequences which flank the sequences of (i), if present, and (ii) and which are homologous to a DHFR nucleic acid sequence which is present endogenously in a cell in order to allow a homologous recombination, and (iv) optionally a sequence encoding a negative selection marker which is outside the homologous DNA sequences (iii).
-
22. A mammalian cell, comprising
(a) at least one inactivated endogenous nucleic acid sequence coding for a DHFR, and (b) at least one recombinase target sequence which is integrated into the genome in the region of the sequence (a).
-
24. A mammalian cell, comprising a heterologous nucleic acid sequence in the region of an endogenous DHFR gene locus, the heterologous sequence comprising
(i) a nucleic acid sequence coding for a DHFR, (ii) a nucleic acid sequence coding for a desired protein, and (iii) at least one recombinase target sequence.
Specification